Skip to content

Evaluation of the Effectiveness of "Hospital-Community" Continuity of Medication Management for Elderly Patients with Chronic Diseases

Evaluation of the Effectiveness of "Hospital-Community" Continuous Drug Treatment Management for Elderly Patients with Chronic Diseases: A Prospective, Non-randomized, Cluster-Controlled Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128674
Enrollment
Unknown
Registered
2026-07-23
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The discharge diagnosis must include at least one of the following: hypertension, type 2 diabetes, chronic obstructive pulmonary disease, or osteoporosis, and be accompanied by other chronic diseases (with a total of at least two comorbidities).

Interventions

control group:Routine care
Intervention group:Multicomponent Transitional Medication Safety Program

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 60 years; 2.Discharge diagnosis includes at least one of the following: hypertension, type 2 diabetes, chronic obstructive pulmonary disease, or osteoporosis, with at least one other co-existing chronic condition (total comorbidities >=2); 3.Number of chronic medications at discharge >=5, excluding temporary orders, pro re nata medications, and short-term courses like antibiotics; 4.At least one change to a chronic medication during hospitalization (including addition, discontinuation, dose adjustment, or substitution); 5.Voluntarily enrolled with a primary care team and able to participate in telephone/home follow-up;

Exclusion criteria

Exclusion criteria: 1.Presence of significant communication barriers, cognitive impairment, severe memory deficits, or psychiatric disorders that would affect intervention adherence or the validity of assessments; 2.Diagnosis of a terminal or severe organic disease (e.g., advanced heart failure, end-stage renal disease, active malignancy) with a life expectancy of <6 months; 3.Concurrent participation in another interventional clinical trial;

Design outcomes

Primary

MeasureTime frame
Proportion of patients with at least one medication-related problem(MRP) and mean MRP rate per patient;

Secondary

MeasureTime frame
Distribution of MRP quantities and types;Unplanned readmission (all-cause);Emergency department visit;Medication?related readmission or emergency department visit;All?cause mortality;Patient knowledge of medication regimen (recall accuracy);Patient satisfaction with pharmaceutical services;Health-related quality of life;Teach-back completion rate;Completion rate of community follow-up;Quality of discharge medication summary;Number and types of interventions by family physician team;Timeliness of receipt of discharge medication summary;Medication adherence;Implementation of medication reconciliation;

Countries

China

Contacts

Public ContactYou Ruxu

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

youruxu2008@163.com+86 27 85726077

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026